Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2018

Open Access 01-12-2018 | Study protocol

Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: a randomized controlled trial

Authors: Giovanni Mansueto, Francesco De Cesaris, Pierangelo Geppetti, Fiammetta Cosci

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

Chronic migraine is a chronic medical condition associated with resistance to pharmacological treatment and poor benefits from the psychological interventions studied to date, including acceptance and commitment therapy or mindfulness. This manuscript describes the rationale and methods for a pilot feasibility study designed to (1) establish and (2) evaluate the feasibility and acceptability of research procedures and interventions to investigate whether well-being therapy improves outcomes relative to a control condition.

Methods

The current intervention will use a randomized controlled trial design, wherein 30 outpatients with chronic migraine will be randomized (1:1) to well-being therapy (n = 15) or to a control condition (n = 15). Primary outcomes include the level of disability caused by migraine and the frequency, duration, and intensity of migraine attacks; the secondary outcomes focus on anxiety, depression, psychological well-being, euthymia, and distress. Primary and secondary outcomes will be assessed at baseline, after sessions 4 and 8, and at 3-month follow-up. The Ethical Review Boards at the University-Hospital Careggi has approved the study (5th December 2017).

Discussion

Identifying medium-term interventions able to improve chronic migraine is relevant to manage this illness. The present randomized trial might represent a step forward for managing chronic migraine by means of psychological interventions.

Trial registration

ClinicalTrial.gov Identifier: NCT03404336. Registered on 19 January 2018.
Appendix
Available only for authorised users
Literature
1.
Ailani J, DeGryse RE, Gillard PJ, Varon SF, Lipton RB, Rosen NL. Pooled results from the PREEMPT randomized clinical trial program. Cephalalgia. 2016;36(9):899–908.CrossRefPubMedPubMedCentral
2.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24(1):9–160.
3.
Headache Classification Committee of the International Headache Society (HIS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;233(9):629–808.CrossRef
4.
Bigal ME, Rapoport A, Sheftell F, Tepper S, Lipton R. The International Classification of Headache Disorders revised criteria for chronic migraine-field testing in a headache specialty clinic. Cephalalgia. 2007;27:230–4.CrossRefPubMed
5.
Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26:742–6.CrossRefPubMed
6.
Manack AN, Buse DC, Lipton RB. Chronic migraine: epidemiology and disease burden. Curr Pain Headache. 2011;15(1):70–8.CrossRef
7.
Cecchini AP, Leone M, Manzoni GC, Torelli P, Bussone G. Drug-resistant chronic migraine: the Italian GON project. Neurol Sci. 2012;33(1):33–5.CrossRef
8.
Andrasik F. Behavioral treatment of migraine: current status and future directions. Expert Rev Neurother. 2004;4:403–13.CrossRefPubMed
9.
D’Souza PJ, Lumley MA, Kraft CA, Dooley JA. Relaxation training and written emotional disclosure for tension or migraine headaches: a randomized, controlled trial. Ann Behav Med. 2008;36:21–32.CrossRefPubMed
10.
Mullally WJ, Hall K, Goldstein R. Efficacy of biofeedback in the treatment of migraine and tension type headaches. Pain Physician. 2009;12:1005–11.PubMed
11.
Nicholson RA, Buse DC, Andrasik F, Lipton RB. Nonpharmacologic treatments for migraine and tension-type headache: how to choose and when to use. Curr Treat Options Neurol. 2011;13:28–40.CrossRefPubMed
12.
Dindo L, Recober A, Marchman J, Turvey C, O’Hara MW. One-day behavioral treatment for patients with comorbid depression and migraine: a pilot study. Behav Res Ther. 2012;50:537–43.CrossRefPubMedPubMedCentral
13.
Dindo L, Recober A, Marchman J, O’Hara MW, Turvey C. One-day behavioral intervention in depressed migraine patients: effects on headache. Headache. 2014;54:528–38.CrossRefPubMedPubMedCentral
14.
Mo’tamedi H, Rezaiemaram P, Tavallaie A. The effectiveness of a group-based acceptance and commitment additive therapy on rehabilitation of female outpatients with chronic headache: preliminary findings reducing 3 dimension of headache impact. Headache. 2012;52:1106–11.CrossRefPubMed
15.
Wells RE, Burch R, Paulsen RH, Wayne PM, Houle TT, Loder E. Meditation for migraines: a pilot randomized controlled trial. Headache. 2015;54:1484–95.CrossRef
16.
Cathcart S, Galatis N, Immink M, Proeve M, Petkov J. Brief mindfulness-based therapy for chronic tension-type headache: a randomized controlled pilot study. Behav Cogn Psychother. 2014;42:1–15.CrossRefPubMed
17.
Feuille M, Pargament K. Pain, mindfulness, and spirituality: a randomized controlled trial comparing effects of mindfulness and relaxation on pain-related outcomes in migraineurs. J Health Psychol. 2015;20(8):1090–106.CrossRefPubMed
18.
Day MA, Thorn BE, Ward LC, Rubin N, Hickman SD, Scogin F, Kilgo GR. Mindfulness-based cognitive therapy for the treatment of headache pain: a pilot study. Clin J Pain. 2014;30:152–61.PubMed
19.
Fava GA. Well-Being Therapy. Treatment Manual and Clinical Applications. Basel: Karger; 2016.CrossRef
20.
Fava GA, Cosci F, Guidi J, Tomba E. Well-being therapy in depression: new insights into the role of psychological well-being in the clinical process. Depress Anxiety. 2017;34(9):801–8.CrossRefPubMed
21.
Fava GA. Well-being therapy: current indications and emerging perspectives. Psychother Psychosom. 2016;85(3):136–45.CrossRefPubMed
22.
Jahoda M. Current Concepts of Positive Mental Health. New York: Basic Books; 1958.CrossRef
23.
24.
Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S. Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry. 2004;161:1872–6.CrossRefPubMed
25.
Stangier U, Hilling C, Heidenreich T, Risch AK, Barocka A, Schlösser R, Kronfeld K, Ruckes C, Berger H, Röschke J, Weck F, Volk S, Hambrecht M, Serfling R, Erkwoh R, Stirn A, Sobanski T, Hautzinger M. Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled study. Am J Psychiatry. 2013;170(6):624–32.CrossRefPubMed
26.
Fava GA, Ruini C, Rafanelli C, Finos L, Salmaso L, Mangelli L, Sirigatti S. Well-being therapy of generalized anxiety disorder. Psychother Psychosom. 2005;74:26–30.CrossRefPubMed
27.
Fava GA, Rafanelli C, Tomba E, Guidi J, Grandi S. The sequential combination of cognitive behavioral treatment and well-being therapy in cyclothymic disorder. Psychother Psychosom. 2011;80:136–43.CrossRefPubMed
28.
Cosci F. Well-being therapy in a patient with panic disorder who failed to respond to paroxetine and cognitive behavior therapy. Psychother Psychosom. 2015;84:318–9.CrossRefPubMed
29.
Garland EL, Howard MO, Zubieta JK, Froeliger B. Restructuring hedonic dysregulation in chronic pain and prescription opioid misuse: effects of mindfulness-oriented recovery enhancement on responsiveness to drug cues and natural rewards. Psychother Psychosom. 2017;86(2):111–2.CrossRefPubMed
30.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar RW, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–7.CrossRefPubMedPubMedCentral
31.
32.
Penzien DB, Andrasik F, Freidenberg BM, Houle TT, Lake AE 3rd, Lipchik GL, Holroyd KA, Lipton RB, McCrory DC, Nash JM, Nicholson RA, Powers SW, Rains JC, Wittrock DA. American Headache Society Behavioral Clinical Trials Workgroup. Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup. Headache. 2005;45(2):110–32.CrossRef
33.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association; 2013.
34.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Herguenta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.) the development and validation of a structured diagnostic interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33.PubMed
35.
Peng KP, Wang SJ. Migraine diagnosis: screening items, instruments, and scales. Acta Anaesthesiol Taiwanica. 2012;50(2):69–73.CrossRef
36.
Tfelt-Hansen P, Block G, Dahlöf C, Diener HC, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, Meinert C, Sandrini G, Steiner T, Winter PB. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000;20(9):765–86.CrossRefPubMed
37.
Cosci F, Ibrahim HMH, Nannini A, Schruers K. Experimental study on the effects of anxiety sensitivity and somatosensory amplification on the response to the 35% CO2 challenge in abstinent smokers. Exp Clin Psychopharmacol. 2015;23(6):464–76.CrossRefPubMed
38.
Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56 (1) Suppl1:20–8.CrossRef
39.
D'amico D, Mosconi P, Genco S, Usai S, Prudenzano AMP, Grazzi L, Leone M, Puca FM, Bussone G. The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia. 2001;21(10):947–52.CrossRefPubMed
40.
Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2:197–207.CrossRefPubMed
41.
Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31(2):73–86.CrossRefPubMed
42.
Kellner R. A symptom questionnaire. J Clin Psychiatry. 1987;48:268–74.PubMed
43.
Fava GA, Kellner R, Perini GI, Fava M, Michelacci L, Munari F, Evangelisti LP, Grandi S, Bernardi M, Mastrogiacomo I. Italian validation of the symptom rating test (SRT) and symptom questionnaire (SQ). Can J Psychiatr. 1983;28(2):117–23.CrossRef
44.
Bech P, Gudex C, Johansen KS. The WHO (ten) Well-being index: validation in diabetes. Psychother Psychosom. 1996;65:83–190.
45.
Ryff C, Keyes C. The structure of psychological well-being revisited. J Pers Soc Psychol. 1995;69:719–27.CrossRefPubMed
46.
Ruini C, Ottolini F, Rafanelli C, Ryff CD, Fava GA. La validazione italiana delle Psychological Well-being Scales (PWB). Riv Psichiatr. 2003;38(3):117–30.
47.
48.
Piolanti A, Offidani E, Guidi J, Gostoli S, Fava GA, Sonino N. Use of the Psychosocial Index: A Sensitive Tool in Research and Practice. Psychother Psychosom. 2016;85(6):337–45.CrossRefPubMed
49.
50.
IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 20.0. Armonk: IBM Corp.
51.
Vickers AJ. Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed data. BMC Med Res Methodol. 2005;5:35.CrossRefPubMedPubMedCentral
52.
Escher CM, Paracka L, Dressler D, Kollewe K. Botulinum toxin in the management of chronic migraine: clinical evidence and experience. Ther Adv Neurol Disord. 2017;10(2):127–35.CrossRefPubMed
53.
Silberstein SD, Dodick DW, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, Grozinski-Wolff M, Yang R, Aycardi E. Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med. 2017;377(22):2113–22.CrossRefPubMed
54.
Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, Taffi R, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia. 2003;23(8):820–84.CrossRefPubMed
55.
Mathew NT, Jaffri SFA. A double-blind comparison of onabotulinumtoxinA (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache. 2009;49(10):1466–78.CrossRefPubMed
Metadata
Title
Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: a randomized controlled trial
Authors
Giovanni Mansueto
Francesco De Cesaris
Pierangelo Geppetti
Fiammetta Cosci
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2944-5

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue

Research

Surveying knowledge, practice and attitudes towards intervention fidelity within trials of complex healthcare interventions

Study protocol

Adolescent depression: Study protocol for a randomized, controlled, double-blind multicenter parallel group trial of Bright Light Therapy in a naturalistic inpatient setting (DeLight)

Study protocol

Assessment of clinical effect and treatment quality of immediate-release carvedilol-IR versus SLOW release carvedilol-SR in Heart Failure patients (SLOW-HF): study protocol for a randomized controlled trial

Study protocol

Prevention of Infections in Cardiac Surgery study (PICS): study protocol for a pragmatic cluster-randomized factorial crossover pilot trial

Study protocol

The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial

Update

Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trial